|
1.
|
de Villiers EM, Fauquet C, Broker TR,
Bernard HU and zur Hausen H: Classification of papillomaviruses.
Virology. 324:17–27. 2004.
|
|
2.
|
Mahmud SM and Franco EL: An overview of
epidemiological and public health research on HPVs presented at the
21st International Papillomavirus Conference in Mexico City, 20–26
February 2004. Papillomavirus Rep. 15:121–123. 2004.
|
|
3.
|
Kitchener HC, Almonte M, Thomson C, et al:
HPV testing in combination with liquid-based cytology in primary
cervical screening (ARTISTIC): a randomised controlled trial.
Lancet Oncol. 10:672–682. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
McLachlin CM: Human papillomavirus in
cervical neoplasia. Role, risk factors, and implications. Clin Lab
Med. 20:257–270. 2000.PubMed/NCBI
|
|
5.
|
Smith JS, Lindsay L, Hoots B, Keys J,
Franceschi S, Winer R and Clifford GM: Human papillomavirus type
distribution in invasive cervical cancer and high-grade cervical
lesions: a meta-analysis update. Int J Cancer. 121:621–632. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Bulkmans NW, Berkhof J, Rozendaal L, et
al: Human papillomavirus DNA testing for the detection of cervical
intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a
randomised controlled implementation trial. Lancet. 370:1764–1772.
2007.
|
|
7.
|
Dillner J, Rebolj M, Birembaut P, et al:
Long term predictive values of cytology and human papillomavirus
testing in cervical cancer screening: joint European cohort study.
BMJ. 337:a17542008. View Article : Google Scholar
|
|
8.
|
Mayrand MH, Duarte-Franco E, Rodrigues I,
et al Canadian Cervical Cancer Screening Trial Study Group: Human
papillomavirus DNA versus Papanicolaou screening tests for cervical
cancer. N Engl J Med. 357:1579–1588. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Naucler P, Ryd W, Törnberg S, et al: Human
papillomavirus and Papanicolaou tests to screen for cervical
cancer. N Engl J Med. 357:1589–1597. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Castle PE, Sadorra M, Lau T, Aldrich C,
Garcia FA and Kornegay J: Evaluation of a prototype real-time PCR
assay for carcinogenic human papillomavirus (HPV) detection and
simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J Clin
Microbiol. 47:3344–3347. 2009. View Article : Google Scholar
|
|
11.
|
Wright TC Jr, Massad LS, Dunton CJ, et al
2006 American Society for Colposcopy and Cervical
Pathology-sponsored Consensus Conference: 2006 consensus guidelines
for the management of women with abnormal cervical cancer screening
tests. Am J Obstet Gynecol. 197:346–355. 2007. View Article : Google Scholar
|
|
12.
|
Bosch FX and de Sanjosé S: Chapter 1:
Human papillomavirus and cervical cancer - burden and assessment of
causality. J Natl Cancer Inst Monogr. 31:3–13. 2003. View Article : Google Scholar
|
|
13.
|
Clifford GM, Smith JS, Plummer M, Muñoz N
and Franceschi S: Human papillomavirus types in invasive cervical
cancer worldwide: a meta-analysis. Br J Cancer. 88:63–73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Muňoz N, Bosch X, de Sanjosé S, et al:
Epidemiologic classification of Human Papilloma Virus types
associated with cervical cancer. N Engl J Med. 348:518–527.
2003.
|
|
15.
|
Poljak M, Ostrbenk A, Seme K, et al:
Comparison of clinical and analytical performance of the Abbott
realtime high risk HPV test to the performance of hybrid capture 2
in population-based cervical cancer screening. J Clin Microbiol.
49:1721–1729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Schiffman M, Wentzensen N, Wacholder S,
Kinney W, Gage JC and Castle PE: Human papillomavirus testing in
the prevention of cervical cancer. J Natl Cancer Inst. 103:368–383.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Apgar BS, Zoschnick L and Wright TC Jr:
The 2001 Bethesda System terminology. Am Fam Physician.
68:1992–1998. 2003.
|
|
18.
|
Ermel A, Qadadri B, Morishita A, et al:
Human papillomavirus detection and typing in thin prep cervical
cytologic specimens comparing the Digene Hybrid Capture II Assay,
the Roche Linear Array HPV Genotyping Assay, and the Kurabo
GeneSquareMicroarray Assay. J Virol Methods. 169:154–161. 2010.
View Article : Google Scholar
|
|
19.
|
Sherman ME, Lorincz AT, Scott DR, et al:
Baseline cytology, human papilomavirus testing, and risk for
cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst.
95:46–52. 2003.PubMed/NCBI
|
|
20.
|
Gage JC, Sadorra M, Lamere BJ, et al PaP
Cohort Study Group: Comparison of the cobas human papillomavirus
(HPV) test with the hybrid capture 2 and linear assay HPV DNA
tests. J Clin Microbiol. 50:61–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Burd EM: Human papillomavirus and cervical
cancer. Clin Microbiol Rev. 16:1–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kaliterna V, Lepej SZ and Vince A:
Comparison between the Abbott RealTime high risk HPV assay and the
Hybrid Capture 2 assay for detecting high-risk human papillomavirus
DNA in cervical specimens. J Med Microbiol. 58:1662–1663. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Kovacic MB, Castle PE, Herrero R, et al:
Relationships of human papillomavirus type, qualitative viral load,
and age with cytologic abnormality. Cancer Res. 66:10112–10119.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Lapierre SG, Sauthier P, Mayrand MH, et
al: Human papillomavirus (HPV) DNA triage of women with atypical
squamous cells of undetermined significance with cobas 4800 HPV and
Hybrid Capture 2 test for detection of high-grade lesions of the
uterine cervix. J Clin Microbiol. 50:1240–1244. 2012. View Article : Google Scholar
|
|
25.
|
Song SH, Hong JH, Kwak SH, Lee JK and Kim
MK: Clinical performance assessment of five human papillomavirus
DNA tests using liquid-based cytology samples. J Obstet Gynaecol
Res. 38:408–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Cortes J, Martinón-Torres F, Ramony Cajal
JM, et al: Primary and secondary prevention of cervical cancers and
vulva: recommendations for clinical practice. Prog Obstet Gynecol.
53(Suppl 1): 1–19. 2010.(In Spanish).
|
|
27.
|
Wong AA, Fuller J, Pabbaraju K, Wong S and
Zaharadia G: Comparison of the hybrid capture 2 and cobas 4800
tests for detection of high-risk human papillomavirus in specimens
collected in PreservCyt medium. J Clin Microbiol. 50:25–29. 2012.
View Article : Google Scholar : PubMed/NCBI
|
